The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.

Background: The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to administer scale developed for screening cognitive deficits. This study presents the diagnostic-specific standardization data for this scale in a sample of schizophrenia and bipolar I disorder patients. Meth...

Descripción completa

Detalles Bibliográficos
Autores: Gómez Benito, Juana, Guilera, Georgina, Pino, Oscar, Rojo, Emilio, Tabarés Seisdedos, Rafael, Safont, Gemma, Martínez Arán, Anabel, Franco. Manuel, Cuesta, Manuel J., Crespo Facorro, Benedicto|||0000-0001-9709-1276, Bernardo, Miguel, Vieta, Eduard, Purdon, Scot E., Mesa, Francisco, Rejas, Javier
Tipo de recurso: artículo
Fecha de publicación:2013
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/30907
Acceso en línea:https://hdl.handle.net/10902/30907
Access Level:acceso abierto
Palabra clave:SCIP-S
Standardization data
Norms
Schizophrenia
Bipolar I disorder
Descripción
Sumario:Background: The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to administer scale developed for screening cognitive deficits. This study presents the diagnostic-specific standardization data for this scale in a sample of schizophrenia and bipolar I disorder patients. Methods: Patients between 18 and 55 years who are in a stable phase of the disease, diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or bipolar I disorder were enrolled in this study. Results: The SCIP-S was administered to 514 patients (57.9% male), divided into two age groups (18–39 and 40–55 years) and two educational level groups (less than and secondary or higher education). The performance of the patients on the SCIP-S is described and the transformed scores for each SCIP-S subtest, as well as the total score on the instrument, are presented as a percentile, z-score, T-scores, and IQ quotient. Conclusions: We present the first jointly developed benchmarks for a cognitive screening test exploring functional psychosis (schizophrenia and bipolar disorder), which provide increased information about patient’s cognitive abilities. Having guidelines for interpreting SCIP-S scores represents a step forward in the clinical utility of this instrument and adds valuable information for its use.

Similares en LA Referencia